Clinical Trial Update: Modified TBF Regimen as Conditioning Regimen Prior to Allo-HSCT for T-ALL/LBL [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a Modified TBF conditioning regimen before allogeneic stem cell transplant in T-ALL/LBL.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoblastic Lymphoma
• T-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Cytarabine + Thiotepa + Fludarabine + Busulfan

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Cytarabine+Thiotepa + Fludarabine + Busulfan, T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma | Phase 2 | Status: UNKNOWN